(PharmaNewsWire.Com, November 16, 2017 ) A growing instance of cancer across the globe is a primary factor boosting revenue growth of the global brachytherapy devices market. Market Research Reports Search Engine (MRRSE) has studied the global brachytherapy devices market in a new report titled ‘Brachytherapy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2022.’ The report focuses on the benefits of brachytherapy as a more effective therapy for the treatment of cancer that employs radiation in doses that are concentrated and localized to the cancer cells. Brachytherapy devices are popular as they facilitate efficient treatment in a relatively shorter time period with low side effects. This is a major growth driver for the global brachytherapy devices market. The report highlights the different drivers and factors likely to impact market growth over the forecast period.
The brachytherapy devices market is estimated to reach a market valuation of US$ 383.7 Mn by 2022 end, expanding at a CAGR of 4.2% during the forecast period.
The global market for brachytherapy devices has been segmented on the basis of technique into low dose rate and high dose rate. The low dose rate segment is anticipated to witness higher demand in the coming years. This segment is projected to be valued at US$ 167.4 Mn by 2017 end, reflective of a value share of 45.7% of the global market. The low dose rate segment is expected to display a Y-o-Y growth of US$ 7.1 Mn.
The brachytherapy devices market is segmented on the basis of end user into oncology treatment centers and hospitals. The global brachytherapy devices market is segregated on the basis of application into breast cancer, skin cancer, cervical cancer, and prostate cancer.
On the basis of region, the global market is segmented into Latin America, Middle East & Africa, North America, Japan, Europe, and Asia Pacific excluding Japan. Undoubtedly, North America will remain the largest regional brachytherapy devices market through 2022. North America is also an attractive market, projected to expand at a CAGR of 4.7% in terms of value. Advanced healthcare infrastructural support coupled with rapidly increasing cases of cancer in Europe makes it another important market to watch out for in the coming years. In terms of CAGR though, Japan holds the second position with a growth rate of 4.2%. The growth in the brachytherapy devices market in Japan can be attributed to increasing research in cancer treatment and efforts to develop advanced treatment equipment.
The report studies the growth and strategies of some of the top companies in the global brachytherapy devices market. Companies profiled in the report include Theragenics Corporation, C. R. Bard, Inc., Cook Medical Incorporated, GE Healthcare, Olympus, Radiadyne L.L.C., Eckert & Ziegler BEBIG S.A., Panacea Medical Technologies Pvt. Ltd., Boston Scientific Corporation, Elekta AB, Isoaid L.L.C., C4 Imaging L.L.C., Huiheng Medical Inc., Varian Medical Systems Inc., and Cianna Medical, Inc.
About MRRSE
Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
